EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C23H24N4O4 |
| Net Charge | 0 |
| Average Mass | 420.469 |
| Monoisotopic Mass | 420.17976 |
| SMILES | O=C1NC(=O)N(Cc2ccccc2)C(=O)C1=CNc1ccc(CN2CCOCC2)cc1 |
| InChI | InChI=1S/C23H24N4O4/c28-21-20(22(29)27(23(30)25-21)16-17-4-2-1-3-5-17)14-24-19-8-6-18(7-9-19)15-26-10-12-31-13-11-26/h1-9,14,24H,10-13,15-16H2,(H,25,28,30) |
| InChIKey | XPPNZOBEJLLGSI-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 5-[[4-(4-morpholinylmethyl)anilino]methylidene]-1-(phenylmethyl)-1,3-diazinane-2,4,6-trione (CHEBI:109768) is a barbiturates (CHEBI:22693) |
| Manual Xrefs | Databases |
|---|---|
| LSM-21196 | LINCS |